VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1560946
Sex: M
Age:
State:

Vax Date: 02/09/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Soreness; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) and PYREXIA (Slight fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN (Soreness) and PYREXIA (Slight fever). At the time of the report, PAIN (Soreness) and PYREXIA (Slight fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1560947
Sex: F
Age: 83
State: FL

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6; Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6; Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6; Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6; Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6; Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6; Patient's left arm became sore and very tender later in evening after receiving 1st dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Patient's left arm became sore and very tender later in evening after receiving 1st dose), FATIGUE (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), HEADACHE (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), MYALGIA (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6) and ARTHRALGIA (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and VITAMINS NOS for an unknown indication. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INJECTION SITE PAIN (Patient's left arm became sore and very tender later in evening after receiving 1st dose). On 02-Mar-2021, the patient experienced FATIGUE (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), HEADACHE (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), MYALGIA (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), ARTHRALGIA (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), CHILLS (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6) and PYREXIA (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6). At the time of the report, INJECTION SITE PAIN (Patient's left arm became sore and very tender later in evening after receiving 1st dose), FATIGUE (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), HEADACHE (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), MYALGIA (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), ARTHRALGIA (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6), CHILLS (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6) and PYREXIA (Next morning, Patient developed fatigue, headache, muscle and joint pain and chills, fever 100.6) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2020, COVID-19: positive (Positive) Positive for 5 weeks. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-030811 (Patient Link).

Other Meds: CRESTOR; VITAMINS NOS

Current Illness:

ID: 1560948
Sex: M
Age: 77
State: OR

Vax Date: 02/27/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: soreness in his arm; body pain; muscle aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in his arm), PAIN (body pain) and MYALGIA (muscle aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in his arm), PAIN (body pain) and MYALGIA (muscle aches). At the time of the report, PAIN IN EXTREMITY (soreness in his arm), PAIN (body pain) and MYALGIA (muscle aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant and treatment medication details were not reported. The patient declined follow-up. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1560949
Sex: F
Age: 61
State: CA

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Laid in bed; Nausea immediately after injection, nausea continues; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Laid in bed) and NAUSEA (Nausea immediately after injection, nausea continues) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Acid reflux (oesophageal). Concomitant products included VITAMINS NOS for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced NAUSEA (Nausea immediately after injection, nausea continues). On 15-Feb-2021, the patient experienced MALAISE (Laid in bed). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) ongoing since an unknown date for Nausea, at an unspecified dose and frequency. At the time of the report, MALAISE (Laid in bed) outcome was unknown and NAUSEA (Nausea immediately after injection, nausea continues) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications also included unspecified acid reflux medication.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1560950
Sex: M
Age: 89
State: NJ

Vax Date: 01/20/2021
Onset Date: 02/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: deyhdrated; lethargic; weak; very severe dizziness; diarrhea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very severe dizziness), DEHYDRATION (deyhdrated), DIARRHOEA (diarrhea), LETHARGY (lethargic) and ASTHENIA (weak) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage 1. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage 2. On 23-Feb-2021, the patient experienced DIARRHOEA (diarrhea). On 24-Feb-2021, the patient experienced DIZZINESS (very severe dizziness). On 02-Mar-2021, the patient experienced LETHARGY (lethargic) and ASTHENIA (weak). On an unknown date, the patient experienced DEHYDRATION (deyhdrated). At the time of the report, DIZZINESS (very severe dizziness), DEHYDRATION (deyhdrated), DIARRHOEA (diarrhea), LETHARGY (lethargic) and ASTHENIA (weak) outcome was unknown. Concomitant medications were not reported. The patient received unspecified medication as a treatment for dizziness.

Other Meds:

Current Illness:

ID: 1560951
Sex: U
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Received only 0.3 ml instead of the full 0.5 ml of the vaccine; Syringe malfunctioned; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of UNDERDOSE (Received only 0.3 ml instead of the full 0.5 ml of the vaccine) and SYRINGE ISSUE (Syringe malfunctioned) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .3 ml. On an unknown date, the patient experienced UNDERDOSE (Received only 0.3 ml instead of the full 0.5 ml of the vaccine) and SYRINGE ISSUE (Syringe malfunctioned). At the time of the report, UNDERDOSE (Received only 0.3 ml instead of the full 0.5 ml of the vaccine) and SYRINGE ISSUE (Syringe malfunctioned) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1560952
Sex: F
Age: 61
State: LA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Fever of 101.2F; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101.2F) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A211A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PYREXIA (Fever of 101.2F). At the time of the report, PYREXIA (Fever of 101.2F) had not resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Body temperature: 101.2 (High) 101.2 degree F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1560953
Sex: F
Age: 65
State: CA

Vax Date: 02/07/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Arm Pain; Rash; Welts - All Over Body; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), RASH (Rash) and URTICARIA (Welts - All Over Body) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No medical history was reported. Concurrent medical conditions included Allergy (unspecified). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy. On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), RASH (Rash) and URTICARIA (Welts - All Over Body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Rash, Urticaria and Pain in extremity, at an unspecified dose and frequency and HYDROCORTISONE ACETATE (CORTIZONE-10 [HYDROCORTISONE ACETATE]) ongoing since an unknown date for Rash, Urticaria and Pain in extremity, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm Pain), RASH (Rash) and URTICARIA (Welts - All Over Body) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1560954
Sex: F
Age: 55
State: GA

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Left Rotator Cuff Hurt; Unable to lift up her left arm; Swollen Lips; Swollen Face; Fever 100.8 F; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021. This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN (Left Rotator Cuff Hurt), LIMB DISCOMFORT (Unable to lift up her left arm), LIP SWELLING (Swollen Lips), FACE OEDEMA (Swollen Face) and PYREXIA (Fever 100.8 F) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The patient's past medical history included Idiopathic angioedema. On 18-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PAIN (Left Rotator Cuff Hurt), LIMB DISCOMFORT (Unable to lift up her left arm), LIP SWELLING (Swollen Lips), FACE OEDEMA (Swollen Face) and PYREXIA (Fever 100.8 F). The patient was treated with DEXAMETHASONE ACETATE (DECADRON [DEXAMETHASONE ACETATE]) ongoing since an unknown date for Face oedema, Lip swelling, Limb discomfort and Pain, at an unspecified dose and frequency. On 19-Jan-2021, LIP SWELLING (Swollen Lips) and FACE OEDEMA (Swollen Face) had resolved. On 24-Jan-2021, PAIN (Left Rotator Cuff Hurt), LIMB DISCOMFORT (Unable to lift up her left arm) and PYREXIA (Fever 100.8 F) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1560955
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pregnancy test: positive (Positive) Positive. No concomitant medication were reported. No treatment medication were reported. Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: Internal review on 20-Jul-2021 resulted in updates to the pregnancy information.

Other Meds:

Current Illness:

ID: 1560956
Sex: F
Age: 72
State: VA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Only had one Moderna vaccine back in January; Myositis; Arm was swollen, hot, rash; Terrible pain up shoulder and down back; Arm was swollen, hot, rash; arm was swollen; Shoulder and back are weak; Strange horizontal dark colored bump on left arm by injection site; Asthma attack, lungs started to tighten and wheezing; This spontaneous case was reported by a nurse and describes the occurrence of ASTHMA (Asthma attack, lungs started to tighten and wheezing), MUSCULOSKELETAL DISCOMFORT (Shoulder and back are weak), VACCINATION SITE MASS (Strange horizontal dark colored bump on left arm by injection site), PRODUCT DOSE OMISSION ISSUE (Only had one Moderna vaccine back in January) and MYOSITIS (Myositis) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced ASTHMA (Asthma attack, lungs started to tighten and wheezing). On 13-Jan-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (Shoulder and back are weak), VACCINATION SITE MASS (Strange horizontal dark colored bump on left arm by injection site), ARTHRALGIA (Terrible pain up shoulder and down back), VACCINATION SITE RASH (Arm was swollen, hot, rash) and VACCINATION SITE SWELLING (arm was swollen). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Only had one Moderna vaccine back in January), MYOSITIS (Myositis) and VACCINATION SITE WARMTH (Arm was swollen, hot, rash). At the time of the report, ASTHMA (Asthma attack, lungs started to tighten and wheezing), MUSCULOSKELETAL DISCOMFORT (Shoulder and back are weak), PRODUCT DOSE OMISSION ISSUE (Only had one Moderna vaccine back in January), MYOSITIS (Myositis), ARTHRALGIA (Terrible pain up shoulder and down back) and VACCINATION SITE SWELLING (arm was swollen) outcome was unknown and VACCINATION SITE MASS (Strange horizontal dark colored bump on left arm by injection site), VACCINATION SITE WARMTH (Arm was swollen, hot, rash) and VACCINATION SITE RASH (Arm was swollen, hot, rash) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication details were not reported. Treatment included antibiotics and inhaler. Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Updated Events and outcome of events. On 13-Jul-2021: Follow up received included no new information; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1560957
Sex: F
Age: 82
State: PA

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: warm at injection site; itchy at injection site; Arm at injection site is red; Swelling at injection site; Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm at injection site), VACCINATION SITE ERYTHEMA (Arm at injection site is red), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE PRURITUS (itchy at injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm at injection site), VACCINATION SITE ERYTHEMA (Arm at injection site is red), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE PRURITUS (itchy at injection site). At the time of the report, VACCINATION SITE WARMTH (warm at injection site), VACCINATION SITE ERYTHEMA (Arm at injection site is red), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE PRURITUS (itchy at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient was prescribed with "Nethyl Prednisolone" 4 mg for her hip. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1560958
Sex: F
Age: 60
State: GA

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: itching; swollen; red; It was 3.5 inches long and 2.5 inches wide; rash; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PRURITUS (itching), SWELLING (swollen), ERYTHEMA (red) and INJECTION SITE HYPERSENSITIVITY (It was 3.5 inches long and 2.5 inches wide) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 25-Feb-2021, the patient experienced PRURITUS (itching), SWELLING (swollen), ERYTHEMA (red), INJECTION SITE HYPERSENSITIVITY (It was 3.5 inches long and 2.5 inches wide) and RASH (rash). At the time of the report, PAIN IN EXTREMITY (sore arm), PRURITUS (itching), SWELLING (swollen), ERYTHEMA (red), INJECTION SITE HYPERSENSITIVITY (It was 3.5 inches long and 2.5 inches wide) and RASH (rash) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information included cold compress and hydrocortisone cream. Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Reporter contact information was updated.

Other Meds:

Current Illness:

ID: 1560959
Sex: M
Age:
State: MA

Vax Date: 02/11/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: shakes; Fever; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shakes) and PYREXIA (Fever) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 on 25-Jan-2021. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced TREMOR (shakes) and PYREXIA (Fever). At the time of the report, TREMOR (shakes) and PYREXIA (Fever) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1560960
Sex: F
Age: 71
State: AZ

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Vaccine was stored incorrectly; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was stored incorrectly) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. No medical history was provided by the reporter. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored incorrectly). On 01-Mar-2021, PRODUCT STORAGE ERROR (Vaccine was stored incorrectly) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD21-041703, MOD21-041814 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Follow-up received include no new information.; Reporter's Comments: This report refers to a case of product storage error for mRNA-1273, lot # 025A21A with no associated AEs.; Sender's Comments: MOD21-041703:crosslinked MOD21-041814:crosslinked

Other Meds:

Current Illness:

ID: 1560961
Sex: F
Age: 76
State: MN

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: vaccination site movement impairment; Vaccination related malaise; felt "runned down" again; shaking so bad that she could not even hold a glass in her hand; she was freezing; started feeling warm; little headache; headache; Fever of 100 F; Felt warm; chills; droopy eyes; felt no ambition; eyes burned; pain in arm went up to her neck; vaccination site pain; pain in arm; rollercoaster episodes since the first shot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (she was freezing), PAIN IN EXTREMITY (pain in arm), VACCINATION SITE MOVEMENT IMPAIRMENT (vaccination site movement impairment), VACCINATION COMPLICATION (Vaccination related malaise) and EYE DISORDER (droopy eyes) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 24M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included MONTELUKAST for Allergy, ATENOLOL, HCTZ, LORAZEPAM, THYROID (ARMOUR THYROID), OMEPRAZOLE, TRIAMCINOLONE ACETONIDE (NASACORT) and IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE) for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), FEELING ABNORMAL (rollercoaster episodes since the first shot) and VACCINATION SITE PAIN (vaccination site pain). On 20-Feb-2021, the patient experienced PAIN (pain in arm went up to her neck). On 21-Feb-2021, the patient experienced EYE DISORDER (droopy eyes), FEELING ABNORMAL (felt no ambition), EYE IRRITATION (eyes burned) and CHILLS (chills). On 22-Feb-2021, the patient experienced FEELING HOT (Felt warm), HEADACHE (headache) and PYREXIA (Fever of 100 F). On 27-Feb-2021, the patient experienced FEELING COLD (she was freezing), TREMOR (shaking so bad that she could not even hold a glass in her hand), FEELING HOT (started feeling warm) and HEADACHE (little headache). On 28-Feb-2021, the patient experienced FEELING ABNORMAL (felt "runned down" again). On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (vaccination site movement impairment) and VACCINATION COMPLICATION (Vaccination related malaise). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 22-Feb-2021, PYREXIA (Fever of 100 F) had resolved. On 27-Feb-2021, FEELING HOT (started feeling warm) and HEADACHE (little headache) had resolved. At the time of the report, FEELING COLD (she was freezing), PAIN IN EXTREMITY (pain in arm), VACCINATION SITE MOVEMENT IMPAIRMENT (vaccination site movement impairment), VACCINATION COMPLICATION (Vaccination related malaise), EYE DISORDER (droopy eyes), FEELING ABNORMAL (felt no ambition), EYE IRRITATION (eyes burned), FEELING HOT (Felt warm), FEELING ABNORMAL (felt "runned down" again), TREMOR (shaking so bad that she could not even hold a glass in her hand), FEELING ABNORMAL (rollercoaster episodes since the last shot), PAIN (pain in arm went up to her neck), VACCINATION SITE PAIN (vaccination site pain), CHILLS (chills) and HEADACHE (headache) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, Body temperature: 100 (Inconclusive) fever of 100 F temperature. On 28-Feb-2021, Body temperature: 100 (Inconclusive) 100 F temperature again. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication also include Nasal Spray for sinus.

Other Meds: ATENOLOL; HCTZ; LORAZEPAM; ARMOUR THYROID; MONTELUKAST; OMEPRAZOLE; NASACORT; IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

Current Illness:

ID: 1560962
Sex: F
Age:
State: VA

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Itchiness around the injection site; Redness around the injection site; Soreness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PAIN (Soreness around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes and Neck pain. Concomitant products included ATORVASTATIN for Cholesterol, METFORMIN for Diabetes, PREGABALIN (LYRICA) for Neck pain. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PAIN (Soreness around the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (Itchiness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PAIN (Soreness around the injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient stated she stopped taking the Lyrica for neck pain because it was not working. Patient reported she had a big red circle around her injection site. The patient rubbed alcohol on it and took a Tylenol.

Other Meds: ATORVASTATIN; METFORMIN; LYRICA

Current Illness: Diabetes; Neck pain

ID: 1560963
Sex: F
Age: 71
State: CA

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Concerned about getting 2nd vaccine; Fast heart rate; Muscle ache; Fatigue; Dizziness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), COVID-19 IMMUNISATION (Concerned about getting 2nd vaccine), HEART RATE INCREASED (Fast heart rate), MYALGIA (Muscle ache) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M024) for COVID-19 vaccination. The patient's past medical history included COVID-19 in January 2021. Concurrent medical conditions included Hay fever. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced DIZZINESS (Dizziness), HEART RATE INCREASED (Fast heart rate), MYALGIA (Muscle ache) and FATIGUE (Fatigue). On an unknown date, the patient experienced COVID-19 IMMUNISATION (Concerned about getting 2nd vaccine). At the time of the report, DIZZINESS (Dizziness), COVID-19 IMMUNISATION (Concerned about getting 2nd vaccine), HEART RATE INCREASED (Fast heart rate), MYALGIA (Muscle ache) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Concomitant medications not provided Treatment information not provided Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Called and reporter declined further follow-up

Other Meds:

Current Illness: Hay fever

ID: 1560964
Sex: M
Age: 73
State: NC

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Temperature 95-96?F; Got the first shot of the vaccine and tested positive for COVID the same day; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got the first shot of the vaccine and tested positive for COVID the same day) and PYREXIA (Temperature 95-96?F) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced COVID-19 (Got the first shot of the vaccine and tested positive for COVID the same day). On an unknown date, the patient experienced PYREXIA (Temperature 95-96?F). At the time of the report, COVID-19 (Got the first shot of the vaccine and tested positive for COVID the same day) and PYREXIA (Temperature 95-96?F) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 95-96 (Inconclusive) Temperature 95-96?F. On 26-Feb-2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Patient got the mRNA-1273 Moderna vaccine on 26-Feb-2021 and a few hours later got a swab test for COVID-19 because patient was scheduled for leg surgery on 01-Mar-2021.

Other Meds:

Current Illness:

ID: 1560965
Sex: F
Age:
State: FL

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Just not right; Sweating; Weakness; did not want to get out of bed; Achiness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Just not right), MYALGIA (Achiness), HYPERHIDROSIS (Sweating) and ASTHENIA (Weakness; did not want to get out of bed) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION COMPLICATION (Just not right), MYALGIA (Achiness), HYPERHIDROSIS (Sweating) and ASTHENIA (Weakness; did not want to get out of bed). At the time of the report, VACCINATION COMPLICATION (Just not right), MYALGIA (Achiness), HYPERHIDROSIS (Sweating) and ASTHENIA (Weakness; did not want to get out of bed) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported. The patient received vaccine at 01:24 PM on 09-Feb-2021 and waited for the allotted 15 minutes. At 10PM, the evening of 09-Feb2-021 the patient went to bed and woke between 1-2AM experiencing achiness, sweating, just not right. The patient experienced weakness all day on 10-Feb-2021. Her symptoms eventually subsided towards the evening. She did not expect the symptoms at that time. The patient was not 100%, but better. On 11-Feb-2021 the patient was still not herself, but planned on showering, washing hair and getting up and out. She felt like she can though. The patient did house chores, which she could care less for, she just felt weakened.

Other Meds:

Current Illness:

ID: 1560966
Sex: F
Age: 66
State: PA

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Dehydration; Itching all over; Upper back pain; Rash here and there; Chills; Body ache/ muscle pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of DEHYDRATION (Dehydration), PRURITUS (Itching all over), BACK PAIN (Upper back pain), RASH (Rash here and there) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported. Concomitant products included DENOSUMAB (PROLIA) and METOPROLOL for an unknown indication. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced DEHYDRATION (Dehydration), PRURITUS (Itching all over), BACK PAIN (Upper back pain), RASH (Rash here and there), CHILLS (Chills) and MYALGIA (Body ache/ muscle pain). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Chills, Myalgia and Upper back pain, at an unspecified dose and frequency. On 27-Feb-2021, DEHYDRATION (Dehydration), PRURITUS (Itching all over), BACK PAIN (Upper back pain), RASH (Rash here and there), CHILLS (Chills) and MYALGIA (Body ache/ muscle pain) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported.

Other Meds: PROLIA; METOPROLOL

Current Illness:

ID: 1560967
Sex: F
Age:
State:

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Nausea; temperature; body ache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), PYREXIA (temperature) and MYALGIA (body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), PYREXIA (temperature) and MYALGIA (body ache). At the time of the report, NAUSEA (Nausea), PYREXIA (temperature) and MYALGIA (body ache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not reported. Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1560968
Sex: F
Age: 82
State: FL

Vax Date: 02/24/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: upper left arm , where received the vaccine , is swollen; Hot upper left arm; Itchy upper left arm; Very painful upper left arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (upper left arm , where received the vaccine , is swollen), FEELING HOT (Hot upper left arm), PRURITUS (Itchy upper left arm) and PAIN IN EXTREMITY (Very painful upper left arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PERIPHERAL SWELLING (upper left arm , where received the vaccine , is swollen), FEELING HOT (Hot upper left arm), PRURITUS (Itchy upper left arm) and PAIN IN EXTREMITY (Very painful upper left arm). At the time of the report, PERIPHERAL SWELLING (upper left arm , where received the vaccine , is swollen), FEELING HOT (Hot upper left arm), PRURITUS (Itchy upper left arm) and PAIN IN EXTREMITY (Very painful upper left arm) outcome was unknown. No concomitant medications were reported. Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1560969
Sex: F
Age: 42
State: GA

Vax Date: 01/13/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Injection Site swelling; Injection site pain; Painful Lymph Node in the left Armpit; Muscle aches; Low fever; General discomfort; All Side Effects listed in the Patient's Fact Sheet; Swollen Lymph Node in the left Armpit; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (All Side Effects listed in the Patient's Fact Sheet), PAIN (Painful Lymph Node in the left Armpit) and LYMPHADENOPATHY (Swollen Lymph Node in the left Armpit) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012L20A) for COVID-19 vaccination. The patient's past medical history included Anxiety since an unknown date, Vitamin B12 deficiency since an unknown date, Insomnia since an unknown date and Hormone replacement therapy. Concurrent medical conditions included Depression (condition was worsening, treatment change to add additional antidepressant). Concomitant products included ALPRAZOLAM from 06-Jun-2011 to an unknown date for Anxiety, CYANOCOBALAMIN from 01-May-2020 to an unknown date for B12 deficiency anaemia, BUPROPION from 21-Feb-2017 to an unknown date for Depression, ZOLPIDEM TARTRATE from 13-Apr-2017 to an unknown date for Insomnia, ESTRADIOL from 10-Dec-2020 to an unknown date for Salpingo-oophorectomy NOS. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021 at 10:40 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION COMPLICATION (All Side Effects listed in the Patient's Fact Sheet) and LYMPHADENOPATHY (Swollen Lymph Node in the left Armpit). On 14-Feb-2021, the patient experienced PAIN (Painful Lymph Node in the left Armpit). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Pain, Injection site pain and Injection site swelling, at an unspecified dose and frequency. On 14-Feb-2021, VACCINATION COMPLICATION (All Side Effects listed in the Patient's Fact Sheet) had not resolved. At the time of the report, PAIN (Painful Lymph Node in the left Armpit) was resolving and LYMPHADENOPATHY (Swollen Lymph Node in the left Armpit) had not resolved. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: The additional information document received on 25-MAY-2021. Reporters information is added. Patient demographic details were added. First dose information is added. Concomitant drugs were added. Events were added.

Other Meds: CYANOCOBALAMIN; BUPROPION; ESTRADIOL; ZOLPIDEM TARTRATE; ALPRAZOLAM

Current Illness: Anxiety; Depression (condition was worsening, treatment change to add additional antidepressant); Insomnia; Vitamin B12 deficiency

ID: 1560970
Sex: F
Age: 75
State: OK

Vax Date: 01/25/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Her vision went disassociated; Double vision; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (Her vision went disassociated) and DIPLOPIA (Double vision) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced VISUAL IMPAIRMENT (Her vision went disassociated) and DIPLOPIA (Double vision). At the time of the report, VISUAL IMPAIRMENT (Her vision went disassociated) and DIPLOPIA (Double vision) outcome was unknown. Reportedly, the patient was taking unspecified medications for unknown indication concomitantly. She reported that she could not determine which vision was the right vision and she had difficulties putting her glasses back in the case. This lasted about a minute to two minutes

Other Meds:

Current Illness:

ID: 1560971
Sex: F
Age:
State: PR

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Chills; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). At the time of the report, CHILLS (Chills) and HEADACHE (Headache) outcome was unknown. Concomitant medications were not reported. treatment details were not reported. This case was linked to MOD-2021-041137 (Patient Link).

Other Meds:

Current Illness:

ID: 1560972
Sex: F
Age: 75
State: FL

Vax Date: 02/22/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Today it looks worse and redder than it ever did; Rash is not itchy but it is longer and redder up and down then side to side; Arm was red and rash like at the injection site; Arm was red and rash like at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021. This spontaneous case was reported by a health care professional and describes the occurrence of CONDITION AGGRAVATED (Today it looks worse and redder than it ever did), RASH ERYTHEMATOUS (Rash is not itchy but it is longer and redder up and down then side to side), VACCINATION SITE ERYTHEMA (Arm was red and rash like at the injection site) and VACCINATION SITE RASH (Arm was red and rash like at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Rash is not itchy but it is longer and redder up and down then side to side), VACCINATION SITE ERYTHEMA (Arm was red and rash like at the injection site) and VACCINATION SITE RASH (Arm was red and rash like at the injection site). On 02-Mar-2021, the patient experienced CONDITION AGGRAVATED (Today it looks worse and redder than it ever did). At the time of the report, CONDITION AGGRAVATED (Today it looks worse and redder than it ever did), RASH ERYTHEMATOUS (Rash is not itchy but it is longer and redder up and down then side to side), VACCINATION SITE ERYTHEMA (Arm was red and rash like at the injection site) and VACCINATION SITE RASH (Arm was red and rash like at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received on 30 April 2021 NNI

Other Meds:

Current Illness:

ID: 1560973
Sex: M
Age: 45
State: GA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), HEADACHE (really bad headache), NECK PAIN (neck ache on left side) and OCULAR DISCOMFORT (right eye feels like there's something in it (like a sty), burns at times) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm sore). On 30-Jan-2021, the patient experienced HEADACHE (really bad headache) and NECK PAIN (neck ache on left side). On 03-Feb-2021, the patient experienced OCULAR DISCOMFORT (right eye feels like there's something in it (like a sty), burns at times). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form and CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) for Adverse event, at a dose of UNK dosage form. On 22-Jan-2021, PAIN IN EXTREMITY (arm sore) had resolved. On 01-Feb-2021, HEADACHE (really bad headache) and NECK PAIN (neck ache on left side) had resolved. At the time of the report, OCULAR DISCOMFORT (right eye feels like there's something in it (like a sty), burns at times) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. On 10-Feb-2021, the right eye still bothered; mornings were better and nights were worse.

Other Meds:

Current Illness:

ID: 1560974
Sex: F
Age: 30
State: CA

Vax Date: 01/04/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: nervousness; anxiety; headaches daily; This spontaneous case was reported by a health care professional and describes the occurrence of HEADACHE (headaches daily), NERVOUSNESS (nervousness) and ANXIETY (anxiety) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 027620A) for COVID-19 vaccination. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced HEADACHE (headaches daily), NERVOUSNESS (nervousness) and ANXIETY (anxiety). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) for Adverse event, at a dose of 1500 mg. At the time of the report, HEADACHE (headaches daily), NERVOUSNESS (nervousness) and ANXIETY (anxiety) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered ANXIETY (anxiety) to be unlikely related. No further causality assessments were provided for HEADACHE (headaches daily) and NERVOUSNESS (nervousness). The patient had anxiety previously and she did not relate that to the vaccine.

Other Meds: MULTIVITAMINS [VITAMINS NOS]

Current Illness:

ID: 1560975
Sex: F
Age: 76
State: PA

Vax Date: 01/27/2021
Onset Date: 02/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Slighly warm at injection site; Area around injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Slighly warm at injection site) and VACCINATION SITE ERYTHEMA (Area around injection site redness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXIN), METOPROLOL SUCCINATE (TOPROL XL), LOSARTAN POTASSIUM (LOSARTIN), ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), ASA, VITAMIN D [VITAMIN D NOS], FISH OIL, ROSUVASTATIN CALCIUM (CRESTOR), TOCOPHERYL ACETATE, UBIDECARENONE (COQ10 [TOCOPHERYL ACETATE;UBIDECARENONE]) and ASCORBIC ACID, BETACAROTENE, COPPER, TOCOFERSOLAN, ZINC (OCUVITE [ASCORBIC ACID;BETACAROTENE;COPPER;TOCOFERSOLAN;ZINC]) for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Slighly warm at injection site) and VACCINATION SITE ERYTHEMA (Area around injection site redness). At the time of the report, VACCINATION SITE WARMTH (Slighly warm at injection site) and VACCINATION SITE ERYTHEMA (Area around injection site redness) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient did not receive any treatment medication. It was reported that the redness was 2 by 2 in area and on 12-Feb-2021 the area was red again but not bright.

Other Meds: LEVOTHYROXIN; TOPROL XL; LOSARTIN; NEXIUM [ESOMEPRAZOLE MAGNESIUM]; ASA; VITAMIN D [VITAMIN D NOS]; FISH OIL; CRESTOR; COQ10 [TOCOPHERYL ACETATE;UBIDECARENONE]; OCUVITE [ASCORBIC ACID;BETACAROTENE;COPPER;TOCOFERSOLAN;ZINC]

Current Illness:

ID: 1560976
Sex: M
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: no antibodies post second dose; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (no antibodies post second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (no antibodies post second dose). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (no antibodies post second dose) outcome was unknown. Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not applicable. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1560977
Sex: M
Age: 81
State: GA

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Dizziness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and FATIGUE (Fatigue) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced DIZZINESS (Dizziness) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Dizziness) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included "Tylenol" - Self medicating to try to alleviate symptoms

Other Meds:

Current Illness:

ID: 1560978
Sex: F
Age: 48
State: MA

Vax Date: 02/11/2021
Onset Date: 02/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: "not felt right"; Palpitations; hot and cold spells; intermittent headaches; general fatigue; Shortness of breath; Weakness; hearing is more sensitive; fever for 2.5 days; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever for 2.5 days), MALAISE ("not felt right"), PALPITATIONS (Palpitations), FEELING OF BODY TEMPERATURE CHANGE (hot and cold spells) and HEADACHE (intermittent headaches) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PYREXIA (fever for 2.5 days), PALPITATIONS (Palpitations), FEELING OF BODY TEMPERATURE CHANGE (hot and cold spells), HEADACHE (intermittent headaches), FATIGUE (general fatigue), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness) and HYPOACUSIS (hearing is more sensitive). On an unknown date, the patient experienced MALAISE ("not felt right"). At the time of the report, PYREXIA (fever for 2.5 days), PALPITATIONS (Palpitations), FEELING OF BODY TEMPERATURE CHANGE (hot and cold spells), HEADACHE (intermittent headaches), FATIGUE (general fatigue), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness) and HYPOACUSIS (hearing is more sensitive) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant information not provided. Treatment information not provided

Other Meds:

Current Illness:

ID: 1560979
Sex: M
Age: 68
State: IL

Vax Date: 02/14/2021
Onset Date: 02/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: his prior tinnitus has got worse after the vaccination; has mild headaches and he never has headaches; fatigue; left pain arm at the injection site; has left side sharped chest pain mostly when he exhales, daily; not been feeling well/not feel like himself,; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (not been feeling well/not feel like himself,), HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily) and FATIGUE (fatigue) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Chest pain and Tinnitus since an unknown date. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced ILLNESS (not been feeling well/not feel like himself,). On 23-Feb-2021, the patient experienced CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily). On an unknown date, the patient experienced HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), FATIGUE (fatigue) and INJECTION SITE PAIN (left pain arm at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Chest pain, at a dose of UNK UNK, 5 times/wk. At the time of the report, ILLNESS (not been feeling well/not feel like himself,), HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily), FATIGUE (fatigue) and INJECTION SITE PAIN (left pain arm at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No Concomitant medications were provided Treatment information included Tylenol around 5 pills since symptoms started

Other Meds:

Current Illness: Tinnitus

ID: 1560980
Sex: F
Age: 77
State:

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: itching; Bright red spot below the injection site (2 by 4 in) which is hot to touch; Bright red spot below the injection site (2 by 4 in) which is hot to touch; Body temperature of 99.0 F; tiredness; SORE ARM; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to the company on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORE ARM), PRURITUS (itching), INJECTION SITE WARMTH (Bright red spot below the injection site (2 by 4 in) which is hot to touch), INJECTION SITE ERYTHEMA (Bright red spot below the injection site (2 by 4 in) which is hot to touch) and PYREXIA (Body temperature of 99.0 F) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (SORE ARM), PYREXIA (Body temperature of 99.0 F) and FATIGUE (tiredness). On 27-Feb-2021, the patient experienced PRURITUS (itching), INJECTION SITE WARMTH (Bright red spot below the injection site (2 by 4 in) which is hot to touch) and INJECTION SITE ERYTHEMA (Bright red spot below the injection site (2 by 4 in) which is hot to touch). On 26-Feb-2021, FATIGUE (tiredness) had resolved. On 27-Feb-2021, PAIN IN EXTREMITY (SORE ARM) and PYREXIA (Body temperature of 99.0 F) had resolved. At the time of the report, PRURITUS (itching), INJECTION SITE WARMTH (Bright red spot below the injection site (2 by 4 in) which is hot to touch) and INJECTION SITE ERYTHEMA (Bright red spot below the injection site (2 by 4 in) which is hot to touch) outcome was unknown. Concomitant medications were not reported. Treatment details were not reported.

Other Meds:

Current Illness:

ID: 1560981
Sex: F
Age: 82
State: MD

Vax Date: 02/24/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Arm red; Arm itchy; Arm warm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm red), PRURITUS (Arm itchy) and FEELING HOT (Arm warm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M029) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Arm red), PRURITUS (Arm itchy) and FEELING HOT (Arm warm). At the time of the report, ERYTHEMA (Arm red), PRURITUS (Arm itchy) and FEELING HOT (Arm warm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications reported were antibiotic for drug use for unknown indication. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow up received on 15-jun-2021 is significant . TCR added event outcome is updated to recovered / resolved.

Other Meds:

Current Illness:

ID: 1560982
Sex: F
Age:
State: IL

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: red arm; itchy arm; painful arm; swollen arm; arm blotch; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red arm), PRURITUS (itchy arm), PAIN IN EXTREMITY (painful arm), PERIPHERAL SWELLING (swollen arm) and RASH MACULAR (arm blotch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ERYTHEMA (red arm), PRURITUS (itchy arm), PAIN IN EXTREMITY (painful arm), PERIPHERAL SWELLING (swollen arm) and RASH MACULAR (arm blotch). On 28-Feb-2021, PERIPHERAL SWELLING (swollen arm) and RASH MACULAR (arm blotch) had resolved. At the time of the report, ERYTHEMA (red arm), PRURITUS (itchy arm) and PAIN IN EXTREMITY (painful arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant information not provided. Treatment included Tylenol

Other Meds:

Current Illness:

ID: 1560983
Sex: F
Age: 78
State: FL

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: right eye hurting; backache; hip ache; very bad headache; lil sore on left arm; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (right eye hurting), BACK PAIN (backache), ARTHRALGIA (hip ache), HEADACHE (very bad headache) and PAIN IN EXTREMITY (lil sore on left arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (lil sore on left arm). On 11-Feb-2021, the patient experienced EYE PAIN (right eye hurting), BACK PAIN (backache), ARTHRALGIA (hip ache) and HEADACHE (very bad headache). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency; ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency and PSEUDOEPHEDRINE at an unspecified dose and frequency. At the time of the report, EYE PAIN (right eye hurting), BACK PAIN (backache), ARTHRALGIA (hip ache), HEADACHE (very bad headache) and PAIN IN EXTREMITY (lil sore on left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant information not provided. Treatment included Aleve, Aspirin, Pseudoephedrine

Other Meds:

Current Illness:

ID: 1560984
Sex: F
Age: 68
State: MI

Vax Date: 01/13/2021
Onset Date: 01/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: chills; Achiness; soreness; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achiness), PAIN (soreness), PYREXIA (fever) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 038K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Jan-2021, the patient experienced PYREXIA (fever). On 13-Jan-2021, the patient experienced MYALGIA (Achiness) and PAIN (soreness). On 10-Feb-2021, the patient experienced CHILLS (chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 14-Jan-2021, MYALGIA (Achiness) and PAIN (soreness) had resolved. On 11-Feb-2021, PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant information not provided. Treatment included Ibuprofen

Other Meds:

Current Illness:

ID: 1560985
Sex: M
Age: 81
State: NY

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Severe Shakes; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Severe Shakes) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced TREMOR (Severe Shakes). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Tremor, at an unspecified dose and frequency. On 25-Feb-2021, TREMOR (Severe Shakes) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1560986
Sex: F
Age:
State: NC

Vax Date: 02/24/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included FISH OIL from 12-Feb-2021 to an unknown date and PRENATAL MULTIVITAMIN + DHA from 12-Feb-2021 to an unknown date for an unknown indication. On 24-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 17-Dec-2020 and the estimated date of delivery was 23-Sep-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the ninth week of the pregnancy. At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Pregnancy test: positive (Positive) Positive. On 12-Feb-2021, Ultrasound scan: normal (normal) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment information was not provided. The patient's positive pregnancy test was on 15-Jan-2021 and estimated date of conception was 23-Sep-2021.

Other Meds: FISH OIL; PRENATAL MULTIVITAMIN + DHA

Current Illness:

ID: 1560987
Sex: F
Age:
State: WI

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Headache that could choke a horse; Round raised circle; Red injection site; Itchy injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Round raised circle), VACCINATION SITE ERYTHEMA (Red injection site), VACCINATION SITE PRURITUS (Itchy injection site) and HEADACHE (Headache that could choke a horse) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced INJECTION SITE SWELLING (Round raised circle), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE PRURITUS (Itchy injection site). On 27-Feb-2021, the patient experienced HEADACHE (Headache that could choke a horse). At the time of the report, INJECTION SITE SWELLING (Round raised circle), VACCINATION SITE ERYTHEMA (Red injection site), VACCINATION SITE PRURITUS (Itchy injection site) and HEADACHE (Headache that could choke a horse) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment included Acetaminophen Q6H

Other Meds:

Current Illness:

ID: 1560988
Sex: F
Age:
State: RI

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included CELECOXIB (CELEBREX) for an unknown indication. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: CELEBREX

Current Illness: Rheumatoid arthritis

ID: 1560989
Sex: F
Age:
State: VA

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Fever 103; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 103) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02UM20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced PYREXIA (Fever 103). At the time of the report, PYREXIA (Fever 103) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Body temperature: 103 (Inconclusive) fever 103. No concomitant medications were provided. Action taken with mRNA-1273 in response to the events was not applicable. Treatment medications were not provided.

Other Meds:

Current Illness:

ID: 1560990
Sex: F
Age: 77
State: PA

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Dizziness; Extreme tiredness; increased urination; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FATIGUE (Extreme tiredness) and POLYURIA (increased urination) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE, ROSUVASTATIN, POTASSIUM CHLORIDE (K-DUR), LOPERAMIDE HYDROCHLORIDE (IMODIUM), ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN B-COMPLEX VITAMIN C, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12), ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and CALTRATE + D PLUS for an unknown indication. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DIZZINESS (Dizziness), FATIGUE (Extreme tiredness) and POLYURIA (increased urination). At the time of the report, DIZZINESS (Dizziness), FATIGUE (Extreme tiredness) and POLYURIA (increased urination) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details were not provided.

Other Meds: OMEPRAZOLE; ROSUVASTATIN; K-DUR; IMODIUM; BABY ASPIRIN; VITAMIN B-COMPLEX VITAMIN C; VITAMIN B 1-6-12; VITAMIN C & ROSEHIP; CALTRATE + D PLUS

Current Illness:

ID: 1560991
Sex: M
Age:
State: TX

Vax Date: 01/11/2021
Onset Date: 02/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: pins and needles on side of the jab; mild pressure when lying on that shoulder; Unable to raise myself from bed; trouble getting up and could not raise his body; shakiness; flu like symptoms; This spontaneous case was reported by a physician and describes the occurrence of TREMOR (shakiness), INFLUENZA LIKE ILLNESS (flu like symptoms), GAIT INABILITY (trouble getting up and could not raise his body), PARAESTHESIA (pins and needles on side of the jab) and LIMB DISCOMFORT (mild pressure when lying on that shoulder) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced TREMOR (shakiness) and INFLUENZA LIKE ILLNESS (flu like symptoms). On 09-Feb-2021, the patient experienced GAIT INABILITY (trouble getting up and could not raise his body). On 10-Feb-2021, the patient experienced GAIT INABILITY (Unable to raise myself from bed). On an unknown date, the patient experienced PARAESTHESIA (pins and needles on side of the jab) and LIMB DISCOMFORT (mild pressure when lying on that shoulder). On 10-Feb-2021, GAIT INABILITY (Unable to raise myself from bed) had resolved. At the time of the report, TREMOR (shakiness), INFLUENZA LIKE ILLNESS (flu like symptoms), GAIT INABILITY (trouble getting up and could not raise his body) and LIMB DISCOMFORT (mild pressure when lying on that shoulder) outcome was unknown and PARAESTHESIA (pins and needles on side of the jab) had not resolved. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The Concomitant medication A-RED per day was started from 2016 via eye route . No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received with Updated Patient demographics. Added Concomitant Drug, Added events and outcome of the events.

Other Meds:

Current Illness:

ID: 1560992
Sex: F
Age: 72
State: NC

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: pain on right arm; back of legs is itching/butt is itching; upper torso is blistering/neck is blistering (comes and goes); headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain on right arm), PRURITUS (back of legs is itching/butt is itching), BLISTER (upper torso is blistering/neck is blistering (comes and goes)) and HEADACHE (headaches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. no medical history is provided and concomitant drugs are provided. Concomitant products included METFORMIN, Generic Crestor and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain on right arm), PRURITUS (back of legs is itching/butt is itching), BLISTER (upper torso is blistering/neck is blistering (comes and goes)) and HEADACHE (headaches). At the time of the report, PAIN IN EXTREMITY (pain on right arm), PRURITUS (back of legs is itching/butt is itching), BLISTER (upper torso is blistering/neck is blistering (comes and goes)) and HEADACHE (headaches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: METFORMIN; Generic Crestor; VITAMIN D 2000

Current Illness:

ID: 1560993
Sex: F
Age: 74
State: SC

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: warmth( at the injection site); itching ( at the injection site); redness( at the injection site); soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warmth( at the injection site)), MYALGIA (soreness), VACCINATION SITE PRURITUS (itching ( at the injection site)) and VACCINATION SITE ERYTHEMA (redness( at the injection site)) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. Concurrent medical conditions included Adhesive tape allergy (Allergy to adhesive), Arthritis since 2017, Hypertension and Insomnia (Patient is taking Amitriptyline once daily for sleep). Concomitant products included TELMISARTAN for Blood pressure management, AMITRIPTYLINE for Sleepiness. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (soreness). On 09-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warmth( at the injection site)). 09-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching ( at the injection site)) and VACCINATION SITE ERYTHEMA (redness( at the injection site)). The patient was treated with HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warmth( at the injection site)), MYALGIA (soreness), VACCINATION SITE PRURITUS (itching ( at the injection site)) and VACCINATION SITE ERYTHEMA (redness( at the injection site)) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-034939, MOD-2021-034939 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow-up received, added medical history, concomitant medications. Updated patient demographics and event outcome.

Other Meds: TELMISARTAN; AMITRIPTYLINE

Current Illness: Adhesive tape allergy (Allergy to adhesive); Arthritis; Hypertension; Insomnia (Patient is taking Amitriptyline once daily for sleep)

ID: 1560994
Sex: F
Age: 84
State: MI

Vax Date: 02/08/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Neck pain; Right leg swelling; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain), PERIPHERAL SWELLING (Right leg swelling) and CHILLS (Chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced NECK PAIN (Neck pain), PERIPHERAL SWELLING (Right leg swelling) and CHILLS (Chills). At the time of the report, NECK PAIN (Neck pain), PERIPHERAL SWELLING (Right leg swelling) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medication reported No Treatment information reported Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow-up received on 26-APR-2021 contains Non-significant information; Reporter details updated

Other Meds:

Current Illness:

ID: 1560995
Sex: F
Age:
State: PA

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm ) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm ). At the time of the report, PAIN IN EXTREMITY (Pain in arm ) had resolved. Patient was taking blood thinner, small dose of cholesterol medication as concomitant medication. No treatment medication were provided. Action taken for Moderna COVID-19 Vaccine was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Non Significant information- Patient denied to follow-up.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am